Evidence map›Paper›PMID 27924424›Full record

ReviewGlycoconjugate journal2017

RGTA

Denis Barritault, Marie Gilbert-Sirieix, Kim Lee Rice, Fernando Siñeriz, Dulce Papy-Garcia, Christophe Baudouin, Pascal Desgranges, Gilbert Zakine, Jean-Louis Saffar, Johan van Neck

Open access · hybridAbstract readReview
In one paragraph

Review in Glycoconjugate journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Denis BarritaultOTR3, 4 rue Française, 75001, Paris, France. denis.barritault@otr3.com.ORCID 0000-0003-0315-7444
Marie Gilbert-SirieixOTR3, 4 rue Française, 75001, Paris, France.
Kim Lee RiceOTR3, 4 rue Française, 75001, Paris, France.
Fernando SiñerizOTR3, 4 rue Française, 75001, Paris, France.
Dulce Papy-GarciaLaboratory Cell Growth and Tissue Repair (CRRET), UPEC 4397/ERL CNRS 9215, Université Paris Est Cretéil, Université Paris Est, F-94000, Créteil, France.
Christophe BaudouinInstitut de la Vision, 17 rue Moreau, 75012, Paris, France.
Pascal DesgrangesDepartment of Vascular Surgery, Hopital Henri Mondor, Université Paris-Est Créteil, 51 avenue du Maréchal de Lattre de Tassigny, 94000, Créteil, France.
Gilbert ZakineService de Chirurgie Plastique et Reconstructrice, 33 rue de la Tour, Paris, 75016, France.
Jean-Louis SaffarEA2496 Laboratoire Pathologies, Imagerie et Biothérapies Oro-Faciales, Faculté de Chirurgie Dentaire, Université Paris Descartes, Sorbonne Paris Cité, 1 rue Maurice Arnoux, 92120, Montrouge, France.
Johan van NeckDepartment of Plastic and Reconstructive Surgery, Erasmus MC - University Medical Center, Rotterdam, The Netherlands.
OTR3 (France) · FRCentre National de la Recherche Scientifique · FRAssistance Publique – Hôpitaux de Paris · FRErasmus MC · NLInstitut de la Vision · FRUniversité Paris Cité · FRUniversité Paris-Est Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of extracellular matrix (ECM) integrity in maintaining normal tissue function is highlighted by numerous pathologies and situations of acute and chronic injury associated with dysregulation or destruction of ECM components. Heparan sulfate (HS) is a key component of the ECM, where it fulfils important functions associated with tissue homeostasis. Its degradation following tissue injury disrupts this delicate equilibrium and may impair the wound healing process. ReGeneraTing Agents (RGTA

Indexed as

AnimalsBiomimetic MaterialsBone and BonesClinical Trials as TopicCorneal InjuriesDrug Evaluation, PreclinicalExtracellular MatrixGastrointestinal TractGlycosaminoglycansHeparan SulfateHumansMusclesProtective AgentsRegenerative MedicineSkinTissue ScaffoldsGlycosaminoglycansHeparan SulfateOTR4120Protective AgentsExtracellular scaffoldHeparan sulfate mimicsRegenerationRGTA®

Identifiers

PMID27924424
PMCPMC5487810
OpenAlexW2559830163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.